Sarepta Therapeutics
Emily DeBarros, MS, has extensive experience in quality assurance and pharmacovigilance within the biotechnology and pharmaceutical industries. Currently serving as Senior Manager of Research and Clinical Development Quality Assurance at Sarepta Therapeutics since April 2022, Emily previously held positions at Takeda as Senior Specialist in Pharmacovigilance & Quality Compliance and at Alnylam Pharmaceuticals as Senior Associate in Quality Assurance - Pharmacovigilance. Earlier in career, Emily gained experience at TESARO, Inc. as a Global Quality Assurance Associate, and held various roles at Walker and Regis College, contributing to child care, laboratory assistance, and teaching support. Emily holds a Master of Science in Regulatory and Clinical Research Management and a Bachelor of Arts in Biology from Regis College.
This person is not in any teams
This person is not in any offices
Sarepta Therapeutics
10 followers
Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a global biotechnology company on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short.